OAKLAND, Calif. (November 27, 2017) – TMG Partners, one of the Bay Area’s largest mixed-use property developers, announced today that biopharmaceutical company Clovis Oncology (NASDAQ: CLVS), an innovator in cancer drugs, signed a ten-year lease for 32,000 square feet at the developer’s 1330 Broadway property in Downtown Oakland. Clovis is expanding its footprint from Mission […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Teichert’s development arm has filed the first commercial project in Sacramento County’s...
ByThe RegistryNovember 3, 2026Nuveen Real Estate has taken control of a 13-property open-air retail portfolio...
ByThe RegistryNovember 3, 2026The $350 million CMBS loan on 225 Bush St., the century-old former...
ByThe RegistryNovember 3, 2026Kidder Mathews' third-quarter Tri-Valley office report puts a $156 million price on...
ByThe RegistryNovember 3, 2026